PubMed:7517211
Annnotations
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 1239-1254 | gene:4353 | denotes | myeloperoxidase |
| T1 | 1321-1354 | disease:C0023487 | denotes | acute promyelocytic leukemia (APL |
| T2 | 1239-1254 | gene:4353 | denotes | myeloperoxidase |
| T3 | 1401-1404 | disease:C0023467 | denotes | AML |
| T4 | 1397-1400 | gene:2187 | denotes | FAB |
| T5 | 1321-1354 | disease:C0023487 | denotes | acute promyelocytic leukemia (APL |
| T6 | 1397-1400 | gene:2187 | denotes | FAB |
| T7 | 1401-1404 | disease:C0023467 | denotes | AML |
| R1 | T0 | T1 | associated_with | myeloperoxidase,acute promyelocytic leukemia (APL |
| R2 | T2 | T3 | associated_with | myeloperoxidase,AML |
| R3 | T4 | T5 | associated_with | FAB,acute promyelocytic leukemia (APL |
| R4 | T6 | T7 | associated_with | FAB,AML |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 316-353 | cell_type | denotes | myeloid and natural killer (NK) cells |
| T2 | 547-553 | protein | denotes | HLA-DR |
| T3 | 556-560 | protein | denotes | CD16 |
| T4 | 627-692 | protein | denotes | myeloid (CD33, CD13, CD15) and NK cell-associated (CD56) antigens |
| T5 | 805-809 | protein | denotes | CD56 |
| T6 | 811-840 | protein | denotes | neural cell adhesion molecule |
| T7 | 845-860 | cell_type | denotes | leukemic blasts |
| T8 | 891-894 | protein | denotes | CD4 |
| T9 | 914-917 | protein | denotes | CD2 |
| T10 | 919-922 | protein | denotes | CD3 |
| T11 | 927-930 | protein | denotes | CD8 |
| T12 | 993-1008 | protein | denotes | T-cell receptor |
| T13 | 1010-1032 | protein | denotes | TCR beta, gamma, delta |
| T14 | 1239-1254 | protein | denotes | myeloperoxidase |
| T15 | 1374-1395 | protein | denotes | microgranular variant |
| T16 | 1397-1408 | protein | denotes | FAB AML-M3v |
| T17 | 1484-1556 | RNA | denotes | promyelocytic/retinoic acid receptor alpha (RAR alpha) fusion transcript |
| T18 | 1652-1666 | DNA | denotes | chromosome 17q |
| T19 | 1675-1687 | DNA | denotes | del(17)(q25) |
| T20 | 1707-1724 | DNA | denotes | t(11;17)(q23;q21) |
| T21 | 1733-1795 | RNA | denotes | promyelocytic leukemia zinc finger/RAR alpha fusion transcript |
| T22 | 1846-1854 | DNA | denotes | t(11;17) |
| T23 | 2172-2176 | protein | denotes | CD16 |
| T24 | 2198-2236 | cell_type | denotes | normal CD56+, CD16- NK precursor cells |
| T25 | 2329-2372 | cell_type | denotes | normal CD56+, CD33+, CD16- counterpart cell |
| T26 | 2570-2598 | cell_type | denotes | myeloid and NK cell lineages |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 7517211-2#145#149#gene945 | 500-504 | gene945 | denotes | CD33 |
| 7517211-2#152#156#gene4684 | 507-511 | gene4684 | denotes | CD56 |
| 7517211-2#159#164#gene3683 | 514-519 | gene3683 | denotes | CD11a |
| 7517211-2#183#187#gene947 | 538-542 | gene947 | denotes | CD34 |
| 7517211-2#56#78#diseaseC0023467 | 411-433 | diseaseC0023467 | denotes | acute myeloid leukemia |
| 7517211-5#204#219#gene4353 | 1239-1254 | gene4353 | denotes | myeloperoxidase |
| 7517211-5#362#365#gene2187 | 1397-1400 | gene2187 | denotes | FAB |
| 7517211-5#286#314#diseaseC0023487 | 1321-1349 | diseaseC0023487 | denotes | acute promyelocytic leukemia |
| 7517211-5#316#319#diseaseC0023487 | 1351-1354 | diseaseC0023487 | denotes | APL |
| 7517211-5#366#369#diseaseC0023467 | 1401-1404 | diseaseC0023467 | denotes | AML |
| 7517211-5#286#314#diseaseC0023487 | 1321-1349 | diseaseC0023487 | denotes | acute promyelocytic leukemia |
| 7517211-5#316#319#diseaseC0023487 | 1351-1354 | diseaseC0023487 | denotes | APL |
| 7517211-5#366#369#diseaseC0023467 | 1401-1404 | diseaseC0023467 | denotes | AML |
| 145#149#gene94556#78#diseaseC0023467 | 7517211-2#145#149#gene945 | 7517211-2#56#78#diseaseC0023467 | associated_with | CD33,acute myeloid leukemia |
| 152#156#gene468456#78#diseaseC0023467 | 7517211-2#152#156#gene4684 | 7517211-2#56#78#diseaseC0023467 | associated_with | CD56,acute myeloid leukemia |
| 159#164#gene368356#78#diseaseC0023467 | 7517211-2#159#164#gene3683 | 7517211-2#56#78#diseaseC0023467 | associated_with | CD11a,acute myeloid leukemia |
| 183#187#gene94756#78#diseaseC0023467 | 7517211-2#183#187#gene947 | 7517211-2#56#78#diseaseC0023467 | associated_with | CD34,acute myeloid leukemia |
| 204#219#gene4353286#314#diseaseC0023487 | 7517211-5#204#219#gene4353 | 7517211-5#286#314#diseaseC0023487 | associated_with | myeloperoxidase,acute promyelocytic leukemia |
| 204#219#gene4353316#319#diseaseC0023487 | 7517211-5#204#219#gene4353 | 7517211-5#316#319#diseaseC0023487 | associated_with | myeloperoxidase,APL |
| 204#219#gene4353366#369#diseaseC0023467 | 7517211-5#204#219#gene4353 | 7517211-5#366#369#diseaseC0023467 | associated_with | myeloperoxidase,AML |
| 204#219#gene4353286#314#diseaseC0023487 | 7517211-5#204#219#gene4353 | 7517211-5#286#314#diseaseC0023487 | associated_with | myeloperoxidase,acute promyelocytic leukemia |
| 204#219#gene4353316#319#diseaseC0023487 | 7517211-5#204#219#gene4353 | 7517211-5#316#319#diseaseC0023487 | associated_with | myeloperoxidase,APL |
| 204#219#gene4353366#369#diseaseC0023467 | 7517211-5#204#219#gene4353 | 7517211-5#366#369#diseaseC0023467 | associated_with | myeloperoxidase,AML |
| 362#365#gene2187286#314#diseaseC0023487 | 7517211-5#362#365#gene2187 | 7517211-5#286#314#diseaseC0023487 | associated_with | FAB,acute promyelocytic leukemia |
| 362#365#gene2187316#319#diseaseC0023487 | 7517211-5#362#365#gene2187 | 7517211-5#316#319#diseaseC0023487 | associated_with | FAB,APL |
| 362#365#gene2187366#369#diseaseC0023467 | 7517211-5#362#365#gene2187 | 7517211-5#366#369#diseaseC0023467 | associated_with | FAB,AML |
| 362#365#gene2187286#314#diseaseC0023487 | 7517211-5#362#365#gene2187 | 7517211-5#286#314#diseaseC0023487 | associated_with | FAB,acute promyelocytic leukemia |
| 362#365#gene2187316#319#diseaseC0023487 | 7517211-5#362#365#gene2187 | 7517211-5#316#319#diseaseC0023487 | associated_with | FAB,APL |
| 362#365#gene2187366#369#diseaseC0023467 | 7517211-5#362#365#gene2187 | 7517211-5#366#369#diseaseC0023467 | associated_with | FAB,AML |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 238-286 | NP | denotes | a previously unrecognized form of acute leukemia |
| C2 | 287-291 | NP | denotes | that |
| C3 | 311-353 | NP | denotes | both myeloid and natural killer (NK) cells |
| C4 | 384-439 | NP | denotes | 350 cases of adult de novo acute myeloid leukemia (AML) |
| C5 | 455-498 | NP | denotes | 20 cases (6%) with a unique immunophenotype |
| C6 | 715-778 | NP | denotes | reverse transcription polymerase chain reaction (RT-PCR) assays |
| C7 | 1083-1279 | NP | denotes | unique morphologic features (deeply invaginated nuclear membranes, scant cytoplasm with fine azurophilic granularity, and finely granular Sudan black B and myeloperoxidase cytochemical reactivity) |
| C8 | 1280-1284 | NP | denotes | that |
| C9 | 1312-1317 | NP | denotes | those |
| C10 | 1420-1432 | NP | denotes | all 20 cases |
| C11 | 1480-1556 | NP | denotes | the promyelocytic/retinoic acid receptor alpha (RAR alpha) fusion transcript |
| C12 | 1560-1573 | NP | denotes | RT-PCR assays |
| C13 | 1729-1795 | NP | denotes | the promyelocytic leukemia zinc finger/RAR alpha fusion transcript |
| C14 | 1797-1806 | NP | denotes | All cases |
| C15 | 1904-1934 | NP | denotes | all-trans retinoic acid (ATRA) |
| C16 | 1952-1963 | NP | denotes | these cases |
| C17 | 1980-1989 | NP | denotes | some APLs |
| C18 | 1990-1994 | NP | denotes | that |
| C19 | 2033-2037 | NP | denotes | ATRA |
| C20 | 2327-2372 | NP | denotes | a normal CD56+, CD33+, CD16- counterpart cell |
| C21 | 2473-2500 | NP | denotes | this form of acute leukemia |
| C22 | 2561-2598 | NP | denotes | both the myeloid and NK cell lineages |
| C23 | 2616-2657 | NP | denotes | the designation myeloid/NK acute leukemia |
| C24 | 2674-2698 | NP | denotes | this new leukemic entity |
| R1 | C2 | C1 | coref-relat | that,a previously unrecognized form of acute leukemia |
| R2 | C8 | C7 | coref-relat | that,"unique morphologic features (deeply invaginated nuclear membranes, scant cytoplasm with fine azurophilic granularity, and finely granular Sudan black B and myeloperoxidase cytochemical reactivity)" |
| R3 | C9 | C7 | coref-pron | those,"unique morphologic features (deeply invaginated nuclear membranes, scant cytoplasm with fine azurophilic granularity, and finely granular Sudan black B and myeloperoxidase cytochemical reactivity)" |
| R4 | C10 | C5 | coref-ident | all 20 cases,20 cases (6%) with a unique immunophenotype |
| R5 | C12 | C6 | coref-ident | RT-PCR assays,reverse transcription polymerase chain reaction (RT-PCR) assays |
| R6 | C13 | C11 | coref-ident | the promyelocytic leukemia zinc finger/RAR alpha fusion transcript,the promyelocytic/retinoic acid receptor alpha (RAR alpha) fusion transcript |
| R7 | C14 | C4 | coref-ident | All cases,350 cases of adult de novo acute myeloid leukemia (AML) |
| R8 | C16 | C14 | coref-ident | these cases,All cases |
| R9 | C18 | C17 | coref-relat | that,some APLs |
| R10 | C19 | C15 | coref-ident | ATRA,all-trans retinoic acid (ATRA) |
| R11 | C21 | C20 | coref-ident | this form of acute leukemia,"a normal CD56+, CD33+, CD16- counterpart cell" |
| R12 | C22 | C3 | coref-ident | both the myeloid and NK cell lineages,both myeloid and natural killer (NK) cells |
| R13 | C24 | C23 | coref-ident | this new leukemic entity,the designation myeloid/NK acute leukemia |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-200 | Sentence | denotes | HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. |
| S2 | 201-354 | Sentence | denotes | We have identified and characterized a previously unrecognized form of acute leukemia that shares features of both myeloid and natural killer (NK) cells. |
| S3 | 355-562 | Sentence | denotes | From a consecutive series of 350 cases of adult de novo acute myeloid leukemia (AML), we identified 20 cases (6%) with a unique immunophenotype: CD33+, CD56+, CD11a+, CD13lo, CD15lo, CD34+/-, HLA-DR-, CD16-. |
| S4 | 563-861 | Sentence | denotes | Multicolor flow cytometric assays confirmed the coexpression of myeloid (CD33, CD13, CD15) and NK cell-associated (CD56) antigens in each case, whereas reverse transcription polymerase chain reaction (RT-PCR) assays confirmed the identity of CD56 (neural cell adhesion molecule) in leukemic blasts. |
| S5 | 862-1034 | Sentence | denotes | Although two cases expressed CD4, no case expressed CD2, CD3, or CD8 and no case showed clonal rearrangement of genes encoding the T-cell receptor (TCR beta, gamma, delta). |
| S6 | 1035-1410 | Sentence | denotes | Leukemic blasts in the majority of cases shared unique morphologic features (deeply invaginated nuclear membranes, scant cytoplasm with fine azurophilic granularity, and finely granular Sudan black B and myeloperoxidase cytochemical reactivity) that were remarkably similar to those of acute promyelocytic leukemia (APL); particularly the microgranular variant (FAB AML-M3v). |
| S7 | 1411-1796 | Sentence | denotes | However, all 20 cases lacked the t(15;17) and 17 cases tested lacked the promyelocytic/retinoic acid receptor alpha (RAR alpha) fusion transcript in RT-PCR assays; 12 cases had 46,XX or 46,XY karyotypes, whereas 2 cases had abnormalities of chromosome 17q: 1 with del(17)(q25) and the other with t(11;17)(q23;q21) and the promyelocytic leukemia zinc finger/RAR alpha fusion transcript. |
| S8 | 1797-2038 | Sentence | denotes | All cases tested (6/20), including the case with t(11;17), failed to differentiate in vitro in response to all-trans retinoic acid (ATRA), suggesting that these cases may account for some APLs that have not shown a clinical response to ATRA. |
| S9 | 2039-2237 | Sentence | denotes | Four of 6 cases tested showed functional NK cell-mediated cytotoxicity, suggesting a relationship between these unique CD33+, CD56+, CD16- acute leukemias and normal CD56+, CD16- NK precursor cells. |
| S10 | 2238-2447 | Sentence | denotes | Using a combination of panning and multiparameter flow cytometric sorting, we identified a normal CD56+, CD33+, CD16- counterpart cell at a frequency of 1% to 2% in the peripheral blood of healthy individuals. |
| S11 | 2448-2658 | Sentence | denotes | Our studies suggest that this form of acute leukemia may arise from transformation of a precursor cell common to both the myeloid and NK cell lineages; thus we propose the designation myeloid/NK acute leukemia. |
| S12 | 2659-2796 | Sentence | denotes | Recognition of this new leukemic entity will be important in distinguishing these ATRA-nonresponsive cases from ATRA-responsive true APL. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 107-121 | other_name | denotes | acute leukemia |
| T2 | 150-199 | other_name | denotes | French-American-British acute myeloid leukemia-M3 |
| T3 | 272-286 | other_name | denotes | acute leukemia |
| T4 | 397-416 | other_name | denotes | adult de novo acute |
| T5 | 417-433 | other_name | denotes | myeloid leukemia |
| T6 | 435-438 | other_name | denotes | AML |
| T7 | 500-546 | other_name | denotes | CD33+, CD56+, CD11a+, CD13lo, CD15lo, CD34+/-, |
| T8 | 547-553 | protein_molecule | denotes | HLA-DR |
| T9 | 556-560 | protein_molecule | denotes | CD16 |
| T10 | 715-778 | other_name | denotes | reverse transcription polymerase chain reaction (RT-PCR) assays |
| T11 | 805-809 | protein_molecule | denotes | CD56 |
| T12 | 811-840 | protein_family_or_group | denotes | neural cell adhesion molecule |
| T13 | 845-860 | cell_type | denotes | leukemic blasts |
| T14 | 891-894 | protein_molecule | denotes | CD4 |
| T15 | 914-917 | protein_molecule | denotes | CD2 |
| T16 | 919-922 | protein_molecule | denotes | CD3 |
| T17 | 927-930 | protein_molecule | denotes | CD8 |
| T18 | 993-1008 | protein_family_or_group | denotes | T-cell receptor |
| T19 | 1090-1110 | other_name | denotes | morphologic features |
| T20 | 1112-1148 | cell_component | denotes | deeply invaginated nuclear membranes |
| T21 | 1150-1165 | cell_component | denotes | scant cytoplasm |
| T22 | 1171-1199 | other_name | denotes | fine azurophilic granularity |
| T23 | 1205-1238 | other_name | denotes | finely granular Sudan black B and |
| T24 | 1239-1254 | protein_molecule | denotes | myeloperoxidase |
| T25 | 1321-1349 | other_name | denotes | acute promyelocytic leukemia |
| T26 | 1351-1354 | other_name | denotes | APL |
| T27 | 1374-1395 | protein_family_or_group | denotes | microgranular variant |
| T28 | 1397-1400 | protein_molecule | denotes | FAB |
| T29 | 1401-1404 | other_name | denotes | AML |
| T30 | 1484-1526 | protein_molecule | denotes | promyelocytic/retinoic acid receptor alpha |
| T31 | 1528-1537 | protein_molecule | denotes | RAR alpha |
| T32 | 1560-1573 | other_name | denotes | RT-PCR assays |
| T33 | 1652-1666 | DNA_molecule | denotes | chromosome 17q |
| T34 | 1675-1687 | DNA_domain_or_region | denotes | del(17)(q25) |
| T35 | 1707-1724 | DNA_domain_or_region | denotes | t(11;17)(q23;q21) |
| T36 | 1733-1768 | RNA_molecule | denotes | promyelocytic leukemia zinc finger/ |
| T37 | 1768-1777 | protein_molecule | denotes | RAR alpha |
| T38 | 1846-1854 | DNA_domain_or_region | denotes | t(11;17) |
| T39 | 1904-1927 | other_organic_compound | denotes | all-trans retinoic acid |
| T40 | 1929-1933 | other_organic_compound | denotes | ATRA |
| T41 | 2033-2037 | other_organic_compound | denotes | ATRA |
| T42 | 2080-2109 | other_name | denotes | NK cell-mediated cytotoxicity |
| T43 | 2158-2171 | other_name | denotes | CD33+, CD56+, |
| T44 | 2172-2176 | protein_molecule | denotes | CD16 |
| T45 | 2198-2236 | cell_type | denotes | normal CD56+, CD16- NK precursor cells |
| T46 | 2329-2372 | cell_type | denotes | normal CD56+, CD33+, CD16- counterpart cell |
| T47 | 2407-2423 | tissue | denotes | peripheral blood |
| T48 | 2427-2446 | multi_cell | denotes | healthy individuals |
| T49 | 2486-2500 | other_name | denotes | acute leukemia |
| T50 | 2632-2642 | other_name | denotes | myeloid/NK |
| T51 | 2643-2657 | other_name | denotes | acute leukemia |
| T52 | 2679-2698 | other_name | denotes | new leukemic entity |
| T53 | 2741-2745 | other_organic_compound | denotes | ATRA |
| T54 | 2771-2775 | other_organic_compound | denotes | ATRA |
| T55 | 2792-2795 | other_name | denotes | APL |